Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial — Federica Casiraghi (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial
Shared by
Giuseppe Remuzzi
Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial
Article
2020
en
Authors
+19 more
FC
Federica Casiraghi
NP
Norberto Perico
MP
Manuel Alfredo Podestà
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2013
Long-term phenotypic characterization of human bone marrow and adipose tissue derived mesenchymal stromal cells
Dean L. Glettig
,
David Kaplan
Article
2021
Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
Manuel Alfredo Podestà
,
Giuseppe Remuzzi
,
Federica Casiraghi
Article
2013
Role Of Long Pentraxin 3 (PTX3) In Wound Closure Induced By Bone Marrow-Derived Mesenchymal Stromal Cells
Claudia Cappuzzello
,
Andrea Doni
,
Erica Dander
,
Fabio Pasqualini
,
Manuela Nebuloni
,
Barbara Bottazzi
,
Alberto Mantovani
,
Andrea Biondi
,
Cecília Garlanda
,
Giovanna D’Amico
Article
2006
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
Yi Zhou
,
Marta Bosch‐Marcé
,
Hiroaki Okuyama
,
Balaji Krishnamachary
,
Hideo Kimura
,
Li Zhang
,
David L. Huso
,
Gregg L. Friedman
Article
2019
Mesenchymal stromal cell-based therapy in kidney diseases and transplantation
Federica Casiraghi
,
Giuseppe Remuzzi
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.